Laminar Pharma, Inc.
Laminar Pharma is a Spanish biotech company founded in 2006 as a spin-off of the University of the Balearic Islands. It specializes in designing and developing drugs based on a novel therapeutic approach called melitherapy, targeting membrane lipids to treat various diseases, including cancer and neurological disorders. The company is committed to translational research, innovation, and addressing unmet medical needs, with a focus on oncology, rare diseases, and pediatric patients. Laminar Pharma has received multiple awards, grants, and recognitions for its scientific and business achievements, and is actively involved in clinical trials, collaborations, and funding rounds to advance its therapies.
Industries
Nr. of Employees
small (1-50)
Laminar Pharma, Inc.
Palma De Mallorca, Islas Baleares, Spain, Europe
Products
Clinical-stage investigational membrane-lipid regulator for oncology (hydroxylated fatty acid)
An investigational hydroxylated fatty-acid class therapeutic that modulates membrane lipid composition; evaluated in multiple clinical studies including early-phase safety/PK/PD studies and a Phase IIb/III glioblastoma trial with combination radiochemotherapy.
Preclinical therapeutic candidates targeting neurodegeneration and inflammation
Preclinical molecules derived from a membrane-lipid therapy platform under investigation for neurological and inflammatory indications.
Clinical-stage investigational membrane-lipid regulator for oncology (hydroxylated fatty acid)
An investigational hydroxylated fatty-acid class therapeutic that modulates membrane lipid composition; evaluated in multiple clinical studies including early-phase safety/PK/PD studies and a Phase IIb/III glioblastoma trial with combination radiochemotherapy.
Preclinical therapeutic candidates targeting neurodegeneration and inflammation
Preclinical molecules derived from a membrane-lipid therapy platform under investigation for neurological and inflammatory indications.
Services
Clinical development and trial management
Design and operational management of multicentre clinical trials including site coordination, safety monitoring, PK/PD assessments and study readouts.
Drug discovery using membrane lipid modulation
Discovery and preclinical development services focused on molecules that modulate membrane lipid composition and domain organization to alter cellular signalling.
Protein production and purification for target characterisation
Recombinant overexpression and purification of membrane-associated and other proteins to support structural, biochemical and inhibitor-development workflows.
Regulatory submissions and strategy
Preparation and management of regulatory filings, agency interactions and designation applications to support clinical development and trial initiation.
Intellectual property management and licensing
Patent filing and portfolio management for therapeutic candidates, and negotiation/execution of licensing agreements.
Clinical development and trial management
Design and operational management of multicentre clinical trials including site coordination, safety monitoring, PK/PD assessments and study readouts.
Drug discovery using membrane lipid modulation
Discovery and preclinical development services focused on molecules that modulate membrane lipid composition and domain organization to alter cellular signalling.
Protein production and purification for target characterisation
Recombinant overexpression and purification of membrane-associated and other proteins to support structural, biochemical and inhibitor-development workflows.
Regulatory submissions and strategy
Preparation and management of regulatory filings, agency interactions and designation applications to support clinical development and trial initiation.
Intellectual property management and licensing
Patent filing and portfolio management for therapeutic candidates, and negotiation/execution of licensing agreements.
Expertise Areas
- Clinical trial management (Phase I–III, including paediatric studies)
- Oncology drug development (glioblastoma and other solid tumours)
- Membrane lipid-targeted therapeutic discovery
- Biomarker discovery and translational research
Key Technologies
- Membrane lipid modulation therapeutics
- Hydroxylated fatty acid small-molecule chemistry
- Recombinant protein expression and purification
- Cell-based functional assays